Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia
- PMID: 10754255
- DOI: 10.1111/j.1574-6968.2000.tb09069.x
Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia
Abstract
Thirteen strains of Burkholderia cepacia from various origins with mucoid and non-mucoid phenotypes were assayed for exopolysaccharide (EPS) production. The EPS were characterized by glycosyl composition analysis and examination of the products resulting from lithium-ethylenediamine and Smith degradations. The results showed that all strains, including the non-mucoid strains, were able to produce EPS exhibiting the same structural features, i.e. presence of one rhamnosyl, three galactosyl, one mannosyl, one glucosyl and one glucuronosyl residues, suggesting that this EPS is representative of the B. cepacia species.
Similar articles
-
Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit.Eur J Biochem. 1999 Mar;260(2):373-83. doi: 10.1046/j.1432-1327.1999.00171.x. Eur J Biochem. 1999. PMID: 10095771
-
Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.J Clin Microbiol. 2000 Apr;38(4):1651-5. doi: 10.1128/JCM.38.4.1651-1655.2000. J Clin Microbiol. 2000. PMID: 10747161 Free PMC article.
-
Structural studies of the acidic exopolysaccharide produced by a mucoid strain of Burkholderia cepacia, isolated from cystic fibrosis.Carbohydr Res. 1996 May 14;285:59-67. doi: 10.1016/s0008-6215(96)90170-6. Carbohydr Res. 1996. PMID: 9011377
-
Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments.Front Cell Infect Microbiol. 2011 Dec 15;1:16. doi: 10.3389/fcimb.2011.00016. eCollection 2011. Front Cell Infect Microbiol. 2011. PMID: 22919582 Free PMC article. Review.
-
[Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem].Ned Tijdschr Geneeskd. 1995 Nov 18;139(46):2343-6. Ned Tijdschr Geneeskd. 1995. PMID: 7501071 Review. Dutch. No abstract available.
Cited by
-
Host evasion by Burkholderia cenocepacia.Front Cell Infect Microbiol. 2012 Jan 11;1:25. doi: 10.3389/fcimb.2011.00025. eCollection 2011. Front Cell Infect Microbiol. 2012. PMID: 22919590 Free PMC article. Review.
-
Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.J Pediatric Infect Dis Soc. 2022 Sep 7;11(Supplement_2):S23-S31. doi: 10.1093/jpids/piac073. J Pediatric Infect Dis Soc. 2022. PMID: 36069898 Free PMC article. Review.
-
Interactions Between Pathogenic Burkholderia and the Complement System: A Review of Potential Immune Evasion Mechanisms.Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34660335 Free PMC article. Review.
-
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.J Clin Microbiol. 2008 Apr;46(4):1470-3. doi: 10.1128/JCM.02273-07. Epub 2008 Feb 6. J Clin Microbiol. 2008. PMID: 18256220 Free PMC article.
-
Multidisciplinary evidences that Synechocystis PCC6803 exopolysaccharides operate in cell sedimentation and protection against salt and metal stresses.PLoS One. 2013;8(2):e55564. doi: 10.1371/journal.pone.0055564. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405172 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical